{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:31:18Z","timestamp":1783661478654,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172567"],"award-info":[{"award-number":["82172567"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intimp.2023.111205","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T03:13:53Z","timestamp":1701227633000},"page":"111205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comprehensive study of clinicopathological and immune cell infiltration and lactate dehydrogenase expression in patients with thymic epithelial tumours"],"prefix":"10.1016","volume":"126","author":[{"given":"Jianghua","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-0793","authenticated-orcid":false,"given":"An","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.111205_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102014","article-title":"Thymic epithelial tumors: From biology to treatment","volume":"86","author":"Conforti","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.intimp.2023.111205_b0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy","volume":"44","author":"de Jong","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2023.111205_b0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jtho.2022.02.001","article-title":"Trends in Incidence and Survival of Patients With Thymic Epithelial Tumor in a High-Incidence Asian Country: Analysis of the Korean Central Cancer Registry 1999 to 2017","volume":"17","author":"Shin","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.intimp.2023.111205_b0020","doi-asserted-by":"crossref","unstructured":"K. Kondo, Y. Monden, Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan, Ann Thorac Surg 76(3) (2003) 878-84; discussion 884-5.","DOI":"10.1016\/S0003-4975(03)00555-1"},{"issue":"2","key":"10.1016\/j.intimp.2023.111205_b0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2559.2008.03088.x","article-title":"Interobserver variation in the classification of thymic tumours\u2013a multicentre study using the WHO classification system","volume":"53","author":"Verghese","year":"2008","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.intimp.2023.111205_b0030","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/his.14167","article-title":"Interobserver variation in the classification of thymic lesions including biopsies and resection specimens in an international digital microscopy panel","volume":"77","author":"Wolf","year":"2020","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.intimp.2023.111205_b0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.111205_b0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","article-title":"We need to talk about the Warburg effect","volume":"2","author":"DeBerardinis","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.intimp.2023.111205_b0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2023.111205_b0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/9780470122822.ch2","article-title":"Lactate dehydrogenases: structure and function","volume":"37","author":"Everse","year":"1973","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2023.111205_b0055","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/0284186X.2015.1043026","article-title":"Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies","volume":"54","author":"Petrelli","year":"2015","journal-title":"Acta Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2023.111205_b0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41571-022-00686-2","article-title":"The multiple roles of LDH in cancer","volume":"19","author":"Claps","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2023.111205_b0065","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2023.111205_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-015-0633-8","article-title":"The c-Myc\u2013LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer","volume":"32","author":"He","year":"2015","journal-title":"Med. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2023.111205_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040450","article-title":"Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma","volume":"11","author":"Daneshmandi","year":"2019","journal-title":"Cancers (basel)"},{"issue":"3","key":"10.1016\/j.intimp.2023.111205_b0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/1759-7714.13750","article-title":"Thymic epithelial tumors: Do we know all the prognostic factors?","volume":"12","author":"Knetki-Wr\u00f3blewska","year":"2021","journal-title":"Thoracic Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2023.111205_b0085","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.21037\/jtd.2017.10.86","article-title":"Elevated pretreatment serum lactate dehydrogenase level predicts inferior overall survival and disease-free survival after resection of thymic carcinoma","volume":"9","author":"Liu","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.111205_b0090","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?","volume":"17","author":"Marx","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111205_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2023.111205_b0100","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1245\/s10434-020-08228-9","article-title":"High neutrophil count as a negative prognostic factor for relapse in patients with thymic epithelial tumor","volume":"27","author":"Okada","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"29","key":"10.1016\/j.intimp.2023.111205_b0105","doi-asserted-by":"crossref","first-page":"47090","DOI":"10.18632\/oncotarget.17478","article-title":"Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis","volume":"8","author":"Janik","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2023.111205_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.629993","article-title":"Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial Tumors","volume":"27","author":"Valdivia","year":"2021","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.intimp.2023.111205_b0115","doi-asserted-by":"crossref","unstructured":"D. Valdivia, B. Fells, S. Puhlvers, D. Theegarten, M. Zaatar, K. Mardanzai, S. Collaud, T. Pl\u00f6nes, B. Heged\u00fcs, G. Stamatis, CRP and LDH levels as biomarkers in thymic epithelial tumors: twenty years single center experience, Zentralblatt f\u00fcr Chirurgie-Zeitschrift f\u00fcr Allgemeine, Viszeral-, Thorax-und Gef\u00e4\u00dfchirurgie 144(S 01) (2019) V23.","DOI":"10.1055\/s-0039-1694113"},{"key":"10.1016\/j.intimp.2023.111205_b0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lungcan.2019.03.016","article-title":"High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors","volume":"132","author":"Lee","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.intimp.2023.111205_b0125","unstructured":"M. Radovich, C.R. Pickering, I. Felau, G. Ha, H. Zhang, H. Jo, K.A. Hoadley, P. Anur, J. Zhang, M. McLellan, R. Bowlby, T. Matthew, L. Danilova, A.M. Hegde, J. Kim, M.D.M. Leiserson, G. Sethi, C. Lu, M. Ryan, X. Su, A.D. Cherniack, G. Robertson, R. Akbani, P. Spellman, J.N. Weinstein, D.N. Hayes, B. Raphael, T. Lichtenberg, K. Leraas, J.C. Zenklusen, N. Cancer Genome Atlas, J. Fujimoto, C. Scapulatempo-Neto, A.L. Moreira, D. Hwang, J. Huang, M. Marino, R. Korst, G. Giaccone, Y. Gokmen-Polar, S. Badve, A. Rajan, P. Strobel, N. Girard, M.S. Tsao, A. Marx, A.S. Tsao, P.J. Loehrer, The Integrated Genomic Landscape of Thymic Epithelial Tumors, Cancer Cell 33(2) (2018) 244-258 e10."},{"issue":"1","key":"10.1016\/j.intimp.2023.111205_b0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0003-4975(91)90478-9","article-title":"Thymoma: results of 241 operated cases","volume":"51","author":"Maggi","year":"1991","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.intimp.2023.111205_b0135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"Scorsetti","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"22","key":"10.1016\/j.intimp.2023.111205_b0140","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1200\/JCO.2009.22.1176","article-title":"Thymic carcinoma associated with paraneoplastic polymyositis","volume":"27","author":"Inoue","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2023.111205_b0145","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/diagnostics12071764","article-title":"Does myasthenia Gravis affect long-term survival in thymic carcinomas? An ESTS database analysis","volume":"12","author":"Lococo","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.intimp.2023.111205_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.592768","article-title":"Combining 18F-FDG PET\/CT and Serum Lactate Dehydrogenase for Prognostic Evaluation of Small Cell Lung Cancer","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111205_b0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.lungcan.2014.08.008","article-title":"Is 18F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A Meta-Analysis","volume":"86","author":"Treglia","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.intimp.2023.111205_b0160","doi-asserted-by":"crossref","unstructured":"M. Yanagawa, N. Tomiyama, Prediction of thymoma histology and stage by radiographic criteria, Thoracic surgery clinics 21(1) (2011) 1-12, v.","DOI":"10.1016\/j.thorsurg.2010.08.008"},{"issue":"1","key":"10.1016\/j.intimp.2023.111205_b0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/diagnostics13010098","article-title":"Is PET\/CT Able to Predict Histology in Thymic Epithelial Tumours? A Narrative Review","volume":"13","author":"Chiappetta","year":"2023","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.intimp.2023.111205_b0170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MNM.0000000000001547","article-title":"Combined clinical and specific positron emission tomography\/computed tomography-based radiomic features and machine-learning model in prediction of thymoma risk groups","volume":"43","author":"Ozkan","year":"2022","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.intimp.2023.111205_b0175","article-title":"Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers, Seminars in cancer biology","author":"Comandatore","year":"2022","journal-title":"Elsevier"},{"issue":"6","key":"10.1016\/j.intimp.2023.111205_b0180","first-page":"442","article-title":"Hypoxia-induced lactate dehydrogenase expression and tumor angiogenesis","volume":"6","author":"Colgan","year":"2007","journal-title":"Clin. Colorectal Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2023.111205_b0185","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/modpathol.2017.6","article-title":"Expression of PD-1 and PD-L1 in thymic epithelial neoplasms","volume":"30","author":"Weissferdt","year":"2017","journal-title":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology Inc"},{"issue":"2","key":"10.1016\/j.intimp.2023.111205_b0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2015.03.003","article-title":"Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma","volume":"88","author":"Katsuya","year":"2015","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2023.111205_b0195","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/JTO.0000000000000429","article-title":"Diffuse high intensity PD-L1 staining in thymic epithelial tumors","volume":"10","author":"Padda","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.intimp.2023.111205_b0200","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3389\/fonc.2019.01055","article-title":"Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors","volume":"9","author":"Song","year":"2019","journal-title":"Front. Oncol."},{"issue":"24","key":"10.1016\/j.intimp.2023.111205_b0205","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","article-title":"Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial","volume":"37","author":"Cho","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.intimp.2023.111205_b0210","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1158\/1078-0432.CCR-16-0434","article-title":"Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma","volume":"22","author":"Yokoyama","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2023.111205_b0215","doi-asserted-by":"crossref","first-page":"e0182665","DOI":"10.1371\/journal.pone.0182665","article-title":"Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors","volume":"12","author":"Arbour","year":"2017","journal-title":"PLoS One"},{"issue":"5795","key":"10.1016\/j.intimp.2023.111205_b0220","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.intimp.2023.111205_b0225","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/jcm8111833","article-title":"PD-L1 expression and tumor-infiltrating lymphocytes in thymic epithelial neoplasms","volume":"8","author":"Higuchi","year":"2019","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.111205_b0230","first-page":"2387","article-title":"Analysis of the tumor microenvironment and mutation burden identifies prognostic features in thymic epithelial tumors","volume":"12","author":"Hou","year":"2022","journal-title":"Am. J. Cancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923015321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923015321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:09:08Z","timestamp":1761588548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923015321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":46,"alternative-id":["S1567576923015321"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111205","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive study of clinicopathological and immune cell infiltration and lactate dehydrogenase expression in patients with thymic epithelial tumours","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111205"}}